MicroRNA-454 Contributes to Sustaining the Proliferation and Invasion of Trophoblast Cells Through Inhibiting Nodal/ALK7 Signaling in Pre-eclampsia
Overview
Molecular Biology
Pharmacology
Authors
Affiliations
MicroRNAs (miRNAs) are emerging as important regulators in the pathogenesis of pre-eclampsia (PE). Recent evidence has reported that miR-454 plays an important role in regulating cell proliferation and invasion. The decreased proliferation and invasion of trophoblast cells contribute to the pathogenesis of PE. However, whether miR-454 is involved in the regulation of trophoblast cell proliferation and invasion remains unknown. In this study, we aimed to investigate the potential role and underlying mechanism of miR-454 in regulating trophoblast cell proliferation and invasion in vitro. We found that miR-454 expression was significantly decreased in placental tissues from PE patients compared to controls. Transfection of miR-454 mimics promoted the proliferation, reduced the apoptosis, and increased invasion of trophoblast cells, while transfection of miR-454 inhibitor showed opposite effects. Bioinformatics analysis showed that activin receptor-like kinase 7 (ALK7) was a potential target gene of miR-454. Dual-luciferase reporter assay showed miR-454 directly targeted the 3'-untranslated region of AKL7. Further experiments showed that miR-454 negatively regulated ALK7 expression. Interestingly, transfection of miR-454 mimics significantly abrogated the inhibitory effect of Nodal on trophoblast cell proliferation and invasion. Moreover, overexpression of ALK7 markedly reversed the promotion effect of miR-454 on trophoblast cell proliferation and invasion. Overall, our results suggest that miR-454 promotes the proliferation and invasion of trophoblast cells by downregulation of ALK7. Our study suggests that miR-454 may play critical roles in the pathogenesis of PE and serve as a potential therapeutic target for treatment of PE.
Research Progress on Extracellular Matrix Involved in the Development of Preeclampsia.
Wang X, Zhang Q, Ren Y, Liu C, Gao H Curr Protein Pept Sci. 2024; 25(7):527-538.
PMID: 38561606 DOI: 10.2174/0113892037284176240302052521.
Lin Z, Wu S, Jiang Y, Chen Z, Huang X, Wen Z J Assist Reprod Genet. 2024; 41(3):591-608.
PMID: 38315418 PMC: 10957806. DOI: 10.1007/s10815-024-03036-6.
Identification of altered miRNAs and their targets in placenta accreta.
Murrieta-Coxca J, Barth E, Fuentes-Zacarias P, Gutierrez-Samudio R, Groten T, Gellhaus A Front Endocrinol (Lausanne). 2023; 14:1021640.
PMID: 36936174 PMC: 10022468. DOI: 10.3389/fendo.2023.1021640.
Ning W, Wu B, Chen Y, Lian J, Chen Y Exp Ther Med. 2023; 25(1):50.
PMID: 36588809 PMC: 9780518. DOI: 10.3892/etm.2022.11749.
Hayder H, Shan Y, Chen Y, OBrien J, Peng C Front Cell Dev Biol. 2022; 10:995462.
PMID: 36263015 PMC: 9575991. DOI: 10.3389/fcell.2022.995462.